- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02510508
Group Version of CRAFT Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed RCT
A Group Version of Community Reinforcement and Family Training (CRAFT) Compared to Self-Directed CRAFT Delivery and Non-intervention: a Three-armed Randomized Clinical Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of this study is to determine the applicability and effectiveness of (a) CRAFT group format in conjunction with the CRAFT self-help book and (b) a CRAFT self-help book (self-directed CRAFT delivery condition), compared to (c) non-intervention (control). The primary aim is increase CSO well- being and reduce CSO health complaints. CSOs will be assessed at baseline (T0), 2 months (end of intervention) (T1), 3 months- (T2), and 6 months follow-up (T3), independently of the assigned condition. Secondary outcomes will encompass cost-effectiveness of both CRAFT interventions. Also, we measure IP engagement and IPs' substance use.
Since the negative consequences of substance abuse are not limited to alcohol- and drug users themselves, it also affects the lives of family members and close friends (CSOs). This study focusses on CSOs to improve their lives. Recruitment will take place in the Netherlands (nation- wide). Assessment and the CRAFT group intervention will be conducted at six different locations (Arnhem, Doetinchem, Ede, Nijmegen, Tiel and Zevenaar, all in the province of Gelderland) in the Netherlands. Participants will be recruited via advertisements on the Internet, social media, websites of IrisZorg (centre for addiction care and sheltered housing ), and subsequently, in local newspapers and flyers located in emergency rooms, general practitioners, family practice clinics, and mental health based treatment agencies.
To obtain information about the presence of psychiatric disorders of the CSOs, a Dutch version of the Mini-International Neuropsychiatric Interview (M.I.N.I.) will be used. After initial assessment, a randomization procedure will be conducted by an independent researcher, who is affiliated to the Erasmus Medical Center, Rotterdam, the Netherlands. CSOs will be informed about the allocation of conditions within 1 week, after initial admission. Several outcome measures will be used in this study. The following will be measured:
- CSO well- being (including physical and psychological health and complaints, quality of life, quality of the relationship, self- efficacy and social support);
- cost-effectiveness of both CRAFT and Self- Directed Delivery compared to non- intervention.
- IP engagement and IP substance use.
Using the primary outcome, CSO well-being, a priori power analysis is completed. Means and standard deviations for CSO well-being, measured with the Beck Depression Inventory (BDI), for Group CRAFT were used (Miller et al., 1999). An effect size was calculated (f = 0.22). The power analysis, conducted with the online program called G-power, indicated that a total sample size of 69 CSOs is needed to achieve a power of 95% for detecting a medium effect size when using the p = 0.05 criterion of statistical significance. These numbers are based on an ANOVA with a within-between subject design. Based on the pilot study of Kirby et al. (1999), 23% drop out after 3- and 6- month follow-up is taken into account. This means that, including the 23% drop-out-rate and based on the sample size of 69, an N of 85 is needed after 3 months and that a total N of 105 is needed to complete all assessments. Summarized, to be able to have at least 69 assessments completed at 6- month follow- up, a total sample size of 105 CSOs is required; with an estimated total drop-out rate of 34%.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Arnhem, Gelderland, Netherlands, 6800
- IrisZorg
-
Doetinchem, Gelderland, Netherlands, 7000
- IrisZorg
-
Ede, Gelderland, Netherlands, 6710
- IrisZorg
-
Nijmegen, Gelderland, Netherlands, 6500
- IrisZorg
-
Tiel, Gelderland, Netherlands, 4000
- IrisZorg
-
Zevenaar, Gelderland, Netherlands, 6900
- IrisZorg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- CSO has concern about and having direct knowledge of alcohol- and/or drug problems of an IP, who is either a first degree relative, intimate partner or close friend.
- Age at least 18 years (the CSO)
- Reports that IP is not currently in addiction treatment (at IrisZorg and elsewhere) and has not received addiction treatment in the past 3 months
- Reports that IP is treatment-refusing
- Evidence (according CSO) that the IP meets criteria for SUDs according to The Structured Clinical Interview for DSM IV axis 1 Disorders (SCID-I)
Exclusion Criteria:
- Does not demonstrate an adequate understanding of their participation, informed consent, and requirements of the protocol, or has insufficient reading abilities to comprehend the Dutch self-help book or does not agree to participate by refusing to sign an informed consent
- CSO meets the DSM-IV criteria for any current SUD diagnosis, through clinical assessment by The Structured Clinical Interview for DSM IV axis 1 Disorders (SCID-I) and the Dutch version of the Mini- International Neuropsychiatric Interview ( M.I.N.I.)
- Refuses to provide valid locator information, allow audiotaped sessions, and/or participate in follow-ups
- Evidence that the IP had received treatment (other than detoxification) for alcohol or drug problems in the prior three months, was mandated by the courts to receive treatment, or was currently motivated to accept treatment
- IP has a recent history of severe domestic violence
- CSO is involved in a concomitant intervention to get the IP in treatment or to improve their own well-being
- CSO fails to complete less than 4 Group CRAFT sessions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group CRAFT
All CSO's who are allocated to CRAFT group condition will be offered seven sessions of a CRAFT Group format.
Each group will meet for 90 minutes weekly and will be completed within 2 months.
The group content is based on the CRAFT techniques described by a training manual written by Roozen, Smith and Meyers (2015).
Furthermore the CSOs in this condition will also receive a Dutch version of the CRAFT self-help book (Self Directed CRAFT Delivery), "Get your loved one sober: Alternatives to nagging, pleading and threatening" (Meyers & Wolfe, 2012).
Groups will engage in a combination of didactic teaching, role-play of new communication styles and discuss their experiences utilizing CRAFT skills.
|
CSOs will receive seven weekly 90 min sessions of CRAFT + Self-Directed CRAFT Delivery
Non-intervention
Other Names:
|
|
Active Comparator: Self-Directed CRAFT Delivery
CSO's allocated to the Self- Directed CRAFT Delivery will receive the Dutch version of the CRAFT self-help book, "Get your loved one sober: Alternatives to nagging, pleading and threatening" (Meyers & Wolfe, 2012).
The book helps CSO's how to utilize the CRAFT model in their daily lives.
It includes guidelines for responding to IP behavior, improving positive communication skills, improving the CSO's own well-being and explains how to engage the IP into treatment.
|
Non-intervention
Other Names:
CRAFT self-help book (Self Directed CRAFT Delivery)
Other Names:
|
|
No Intervention: Non-intervention
Participants assigned to the non-intervention condition will be placed on a Group CRAFT waiting list.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concerned Significant Other (CSO) well-being (physical and psychological)
Time Frame: 4 months after the initiation of the intervention
|
Measured by the following tests:Measurement of the Addictions for Triage and Evaluation (MATE), Depression Anxiety Scales (DASS-21), Maudsley Addiction Profile (MAP), Research and Development- 36 (RAND- 36), Trimbos/iMTA questionnaire for Costs Associated with Psychiatric Illness (TicP) and EuroQol- 5D.
|
4 months after the initiation of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CSO quality of life
Time Frame: 4 months after the initiation of the intervention
|
Measured by the following tests: CRA- Happiness Scale (CRA-HS) and WHOQol- Bref
|
4 months after the initiation of the intervention
|
|
CSO quality of the relationship
Time Frame: 4 months after the initiation of the intervention
|
Measured by the following tests: CRA Relationship Happiness Scale (CRA-RHS), Agression Questionnaire (AQ) and Experiences in Close Relationships Scale- short form (ECR)
|
4 months after the initiation of the intervention
|
|
Other CSO reported psychological measures
Time Frame: 4 months after the initiation of the intervention
|
Measured by the following tests: General Self-Efficacy Scale (GSES) and Social Support Inventory (SSI).
|
4 months after the initiation of the intervention
|
|
Cost-effectiveness of group CRAFT and Self-Directed CRAFT Delivery compared to non-intervention condition
Time Frame: 4 months after the initiation of the intervention
|
Measured by: TiC-P; EuroQol- 5D and RAND-36
|
4 months after the initiation of the intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identified Patient (IP) engagement for all three conditions
Time Frame: 4 months after the initiation of the intervention
|
Attending at least 1 treatment session
|
4 months after the initiation of the intervention
|
|
CSO Drop-out
Time Frame: 4 months after the initiation of the intervention
|
Drop-out and treatment retention
|
4 months after the initiation of the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hendrik G Roozen, PhD, University of New Mexico; Department of Psychology/ CASAA
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL48307.028.14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorder
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorder | Opioid Use Disorder | Heroin Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Wake Forest University Health SciencesUniversity of Chicago; Rogers Behavioral Health; University of California Santa...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
Clinical Trials on Group CRAFT
-
Centre for Addiction and Mental HealthMclean HospitalCompletedSchizophrenia Spectrum and Other Psychotic Disorders | Substance Use | Substance Use Disorders | Psychosis | Schizophrenia and Related DisordersCanada
-
Stanford UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); University of Southern... and other collaboratorsRecruitingAlcohol Drinking | Alcohol Use Disorder | Alcohol Abuse | Military Family | Relations, InterpersonalUnited States
-
Mclean HospitalNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Tobacco Use | Bipolar Disorder | Cannabis | Substance Use | Substance Use Disorders | Psychosis | Alcohol Use Disorder | Mental Disorder | Cigarette Smoking | Nicotine Use Disorder | Family | Marijuana | AlcoholUnited States
-
Hadassah Medical OrganizationHebrew University of Jerusalem; Israel Cancer AssociationRecruitingBreast Cancer Survivor | Cancer Related Cognitive ImpairmentIsrael
-
VA Office of Research and DevelopmentMinneapolis Veterans Affairs Medical Center; Corporal Michael J. Crescenz VA...Active, not recruitingStress Disorders, Post-traumaticUnited States
-
Mclean HospitalNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Cannabis | Substance Use | Substance Use Disorders | Psychosis | Mental Disorder | Family | Marijuana | AlcoholUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownRefractory SchizophreniaBrazil
-
University of New MexicoNational Institute on Drug Abuse (NIDA)CompletedSubstance Use Disorders | Family MembersUnited States
-
Case Western Reserve UniversityExpanding Horizons InitiativeRecruitingDepression | Anxiety | MoodUnited States
-
University of CincinnatiNational Institute on Drug Abuse (NIDA); MaryhavenUnknownHeroin Dependence | Opiate Dependence | Substance DependenceUnited States